The United States will pay Sanofi and GSK 2.1 billion dollars for the vaccine from COVID-19

The US government has concluded with the companies Sanofi and GlaxoSmithKline an agreement to provide 100 million doses of vaccine against coronavirus infection. Under the agreement us authorities will be able in the future to buy another 500 million doses, Reuters writes.

For a guaranteed supply of 100 million doses the U.S. government will pay the companies $ 2.1 billion, and a big part of the sum paid to Sanofi. When calculating the per person cost of vaccination (to develop immunity against COVID-19 requires the introduction of two doses of vaccine) will be $ 42. This price is comparable to the cost of the vaccine, Pfizer and BioNTech, over 100 million doses of which the American government paid $ 2 billion (or $ 40 for the vaccination of one person).

It is expected that clinical studies of joint development of Sanofi and GSK will begin in September.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]